The Biggest Billionaire Winners & Losers Of 2014
CapitalCube | Jan 09, 2015 01:33AM ET
We know, we know, Bill Ackman won 2014. But Larry Robbins and David Einhorn haven’t done too shabby, either.
Likewise, it’s no secret this year hasn’t been Carl Icahn’s favorite on record (when it comes to investing, at least). And 2014 has left Leon Cooperman licking his wounds as well.
But despite a tough year for hedge funds, many of the crème de la crème on Wall Street did pretty well – even on just equity investments alone.
Robbins, Einhorn Trail Ackman, Still Come Out Strong
From the start of the year through market close Friday, Bill Ackman’s equity investments produced a total return of +46.61%.
His investments in companies like Burger King (NYSE:BKW) and Air Products and Chemicals Inc (NYSE:APD) pushed the Pershing Square portfolio higher. Moreover, the Ackman’s highly-publicized bid for Allergan Inc (NYSE:AGN) turned out to be one of his best plays in years – a major feat, considering it didn’t exactly turn out as planned.
But Ackman isn’t 2014’s only big story – or strong performer.
Both Larry Robbins and David Einhorn put in good years as well. Their total equity returns hit +18.17% and +18.16% respectively, above the +15.30% gain posted by the S&P 500 and the +11.46% climb from the Dow Jones.
Robbins’ secret sauce? Health care. Investments in Humana Inc (NYSE:HUM), Tenet Healthcare Corporation (NYSE:THC) and Thermo Fisher Scientific Inc (NYSE:TMO) drove gains for Glenview Capital in 2014. Side note: Robbins’ most recent buys indicate he thinks consumer discretionary (namely, cars and clothes) may be the way to go in 2015 .
As for David Einhorn, it’s tech bets such as Apple Inc (NASDAQ:AAPL) and Micron Technology Inc (NASDAQ:MU) that have made bank. And we can’t forget that interesting little play in turning BioFuel to Green Brick Partners Inc (NASDAQ:GRBK).
Equity Investments Tough – But Not Terrible – for Cooperman and Icahn
Both Leon Cooperman and Carl Icahn have acknowledged that, investment-wise, 2014 hasn’t been awesome.
“We are having a mediocre year, but our philosophy is if you made money for the clients, you get paid. If you lose money, you don’t. Very simple but fair approach,” the Omega Advisors head wrote in an email CNBC. “Having done this for 46 years, I can tell you it’s a marathon and not a sprint. Or as the Brooklyn Dodgers used to say, ‘Wait ’till next year!’”
Get The News You Want
Icahn touched on the issue in his November letter to Icahn Enterprises investors. “As I’ve said in the past, while I am extremely proud of our long term record, there have always been sporadic speed bumps along the road. However, I believe over the long term, our model continues to be one of the best in the world,” he reflected.
While they’re not racking up wins, in terms of equity investments, Cooperman or Icahn haven’t done that bad this year, either. Cooperman’s public equity portfolio has lost -4.20%, and Icahn’s just -0.39%.
The billionaire whose equity performance has really lagged in 2014: Wilbur Ross, down -22.78% through market close Friday.
In the Green Overall
Of the 20 billionaire investors tracked by iBillionaire, only three will end the year in the red in terms of total equity return performance.
Julian Robertson, Dan Loeb, David Tepper and Steve Mandel returned upwards of +10% this year, and Warren Buffett’s public equity portfolio climbed +8.90%. On average, the equity holdings of the billionaires tracked gained +9.43%. Also worth noting: the iBillionaire Index’s +11.67% climb.
Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.